y.ramos

TL2 · Plovdiv

Contributes reviews on supplier material. Based in Plovdiv.

Joined 23 December 2024 · last posted 2d

85 posts, newest first. Showing up to 150.

Follow-up: How compounding permissions changed when supply normalised Replied, post #76 · Sourcing › Regulatory · 26 Jul 2026 · 29 likes Helpful, and short, which on this subject is harder than long.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #52 · Pharmacology › Receptor biology · 22 Jul 2026 · 3 likes Post #50 describes the usual case. This is about the unusual one. Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is…
Request: a per-category review queue Replied, post #112 · Meta › Feature requests · 18 Jul 2026 · 0 likes Request that would help newcomers more than regulars: show the subcategory description on hover in the category list. The names are terse and the descriptions are good.
I joined for one answer and stayed for a year — what changed my mind Replied, post #76 · Start Here › Welcome · 11 Jul 2026 · 19 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
Seven-day rolling means and why weekly readings mislead Replied, post #12 · Outcomes › Progress reports · 11 Jul 2026 · 0 likes Worth separating two things that post #8 runs together. A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #86 · Compounds › Repair & healing peptides · 7 Jul 2026 · 0 likes An update on my earlier Stability of BPC-157 post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
What to include when your question involves a chromatogram — one year on Replied, post #64 · Start Here › How to Ask · 5 Jul 2026 · 5 likes Where I part company with post #62, and it is a narrow parting. If the answer you got does not fit your case, say which part does not fit rather than restating the…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #76 · Wellbeing › Sleep · 4 Jul 2026 · 19 likes Reading rather than contributing, but this is the most useful thread I have found on it.
About the Welcome category Replied, post #8 · Start Here › Welcome · 30 Jun 2026 · 0 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
Semaglutide and alcohol: what is actually documented Replied, post #12 · Compounds › Semaglutide · 26 Jun 2026 · 0 likes Picking up post #9: that is the part I would want checked first. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #120 · Clinical › Bloodwork · 23 Jun 2026 · 0 likes The confident answers on reference intervals and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #69 · Practice › Interactions · 22 Jun 2026 · 3 likes Where the widely repeated interaction claim reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #22 · Evidence › Journal club · 8 Jun 2026 · 30 likes Answering the question post #20 raises rather than the one it answers. The baseline characteristics table is the single most useful page for the questions that get…
Blinding yourself: practical methods and their limits Replied, post #31 · Research Methods › N-of-1 designs · 4 Jun 2026 · 2 likes I had read the opposite somewhere and cannot now find where, which tells me something.
A critique that turned out to be unfair, retracted by its author Replied, post #7 · Evidence › Study critique · 4 Jun 2026 · 0 likes Post #4 is right about the mechanism and I think understates the practical bit. Blinding, duration and comparator choice trade against each other. Improving one usually…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #65 · Compounds › Repair & healing peptides · 3 Jun 2026 · 10 likes Building on post #64 rather than restating it. Solubility in this family is generally good, which means a vial that will not go into solution readily is telling you…
Why the timeline is on the right and not the left — what changed since Replied, post #43 · Meta › Site feedback · 26 May 2026 · 8 likes Not a bug, but worth saying: the moderation log is paginated at twenty-five entries and there is no way to filter it by rule. Being able to read every R6 action in…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #46 · Sourcing › Red flags · 14 May 2026 · 7 likes The version of supplier that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…
How shortages have affected compounding permissions — does this still hold? Replied, post #2 · Access › Shortages · 12 May 2026 · 7 likes Shortages is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Does a peptide degrade silently, with no visual change? Replied, post #24 · Practice › Storage & stability · 10 May 2026 · 8 likes This follows post #21 rather than contradicting it. Peptide is a question about a distribution, not about a value, and treating it as a value is what produces the…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #62 · Sourcing › Logistics · 6 May 2026 · 8 likes Having read the whole Regional warehouse stock versus direct thread before replying: the question in the first post has not actually been answered yet, and three of us…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #88 · Practice › Reconstitution · 23 Apr 2026 · 0 likes Confirming post #87 from a second method, which matters more than confirming it from a second person. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #63 · Practice › Reconstitution · 22 Apr 2026 · 11 likes That matches what I have seen, for whatever a single anecdote is worth.
The headache that turns out to be dehydration — the long version Replied, post #20 · Nutrition & Training › Hydration & electrolytes · 11 Apr 2026 · 18 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #73 · Compounds › Tirzepatide · 7 Apr 2026 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Follow-up: State-level differences that actually matter Started this topic · Regional › North America · 3 Apr 2026 · 25 likes State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A follow-up question about State-level differences…
Why this subcategory is stricter about sourcing than most Replied, post #11 · Compounds › Secretagogues & GH axis · 24 Mar 2026 · 1 like Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
Revisiting: Maintainer handover: how it works Replied, post #49 · Meta › Wiki maintenance · 13 Mar 2026 · 5 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. I have written this out at length because the short version…
Amylin receptor signalling and satiety — what changed since Replied, post #42 · Pharmacology › Receptor biology · 10 Mar 2026 · 4 likes Mechanistic plausibility has a poor record of predicting clinical outcomes across this whole field. It is a good reason to run the trial and a bad reason to skip it.
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #64 · Pharmacology › Pharmacokinetics · 8 Mar 2026 · 8 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #7 · Lounge › Introductions · 7 Mar 2026 · 21 likes Clinician voices are genuinely welcome and are asked to be explicit about the line. Several members here say plainly in every post that they are describing general…
MHRA statements, read directly Replied, post #102 · Regional › UK & Ireland · 5 Mar 2026 · 2 likes Post #98 put the caveat in the right place and I want to underline it. My position on MHRA statements is current rather than settled. I have revised it once already and…
Contributing data without breaching anyone's privacy Replied, post #37 · Data & Tools › Datasets · 4 Mar 2026 · 9 likes Thank you for taking the time. That was more work than a reply usually is.
Solubility limits and what a cloudy solution is telling you Replied, post #4 · Pharmacology › Formulation chemistry · 26 Feb 2026 · 2 likes Building on post #3 rather than restating it. Buffer choice affects both solubility and stability, and the two do not always point the same way. A formulation is a…
Second pass at: The topic list is dense — is that deliberate? Replied, post #77 · Meta › Site feedback · 20 Feb 2026 · 17 likes Feature request framed as feedback: the category list is long enough that a first-time reader cannot tell which four categories carry most of the traffic. A count next…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #94 · Compounds › Oral incretins · 1 Feb 2026 · 4 likes On post #90 — agreed on the reasoning, with one qualification. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
Managing an unplanned gap in supply Replied, post #6 · Access › Shortages · 14 Jan 2026 · 14 likes Device availability and compound availability are separate supply chains and the device is frequently the constraint.
A partial dose because the pen emptied mid-injection Replied, post #46 · Practice › Administration · 8 Jan 2026 · 1 like Picking up post #43: that is the part I would want checked first. Partial dose because the pen sits at the boundary between what this community can usefully discuss and…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #18 · Data & Tools › Calculators · 8 Jan 2026 · 0 likes Post #15 is right about the mechanism and I think understates the practical bit. Unit-conversion tools are only as good as the assumption they make about the syringe.…
MHRA statements, read directly Replied, post #57 · Regional › UK & Ireland · 28 Dec 2025 · 2 likes Where guidance distinguishes between indications, quoting the indication is essential. The same compound has different positions under different indications. I would…
Aggregates and why a purity assay may miss them entirely Replied, post #28 · Analytics › Impurities & related substances · 25 Dec 2025 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
The anatomy of a question that gets answered within an hour — the long version Replied, post #114 · Start Here › How to Ask · 19 Nov 2025 · 0 likes Confirming post #113 from a second method, which matters more than confirming it from a second person. A photograph of a vial is rarely useful and a photograph of a…
[2026 update] What steady state means for the decision to escalate Replied, post #120 · Practice › Dosing & titration · 17 Nov 2025 · 8 likes Narrowing post #119, because the general version has more than one answer. Holding at a dose that is working is a legitimate position and it is not what the trial…
Pen dose counters: what a click does and does not guarantee Replied, post #63 · Devices › Pens & autoinjectors · 16 Nov 2025 · 11 likes Travel with a pen raises a cold-chain question and a documentation question. The second is the one people forget until an airport. I would want to see it done twice…
Documentation that appears only after payment Replied, post #78 · Sourcing › Red flags · 16 Nov 2025 · 0 likes Worth separating two things that post #74 runs together. I read the earlier replies on documentation twice before writing this, because I had assumed the opposite and…
Realistic expectations for strength while losing weight quickly Replied, post #33 · Nutrition & Training › Resistance training · 3 Nov 2025 · 26 likes That reframing is the whole thing. The facts I already had.
Follow-up: The decimal-point error, and the habit that catches it Replied, post #84 · Practice › Reconstitution · 23 Oct 2025 · 1 like Everything in post #81 holds. The case it does not cover is the one I have. Preservative effectiveness is tested against a defined microbial challenge under defined…
New subcategory: rationale and scope Replied, post #59 · Meta › Announcements · 19 Oct 2025 · 25 likes I have no financial interest in anything named in this thread and I want to say so before I comment on new subcategory, because it is the sort of subject where it…
Titles that describe the question, not the situation Replied, post #110 · Start Here › How to Ask · 1 Oct 2025 · 5 likes Speaking only to titles as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #108 · Practice › Side effects · 1 Oct 2025 · 6 likes Coming back to post #104, because the follow-up matters more than the original answer. The published rates come from populations that were titrated on a defined…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #66 · Compounds › Semaglutide · 28 Sep 2025 · 7 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #16 · Compounds › Semaglutide · 16 Sep 2025 · 33 likes Coming back to post #14, because the follow-up matters more than the original answer. Semaglutide solutions is well covered in the tag pages, and the older discussions…
"Should I double up?" — answered once, at length, calmly Replied, post #14 · Practice › Administration · 26 Aug 2025 · 0 likes That reframing is the whole thing. The facts I already had.
Coming back to: Official shortage notices and what they authorise Replied, post #91 · Access › Shortages · 15 Aug 2025 · 16 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
A request that was declined, and the reasoning — a second dataset Replied, post #52 · Documentation › Wiki requests · 11 Aug 2025 · 0 likes Post #48 put the caveat in the right place and I want to underline it. The commonest reason a good request stalls is that nobody converted it into a draft. A rough…
[2026 update] An appeal that failed, and what I would do differently Replied, post #25 · Access › Insurance & coverage · 8 Jun 2025 · 19 likes This follows post #23 rather than contradicting it. Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current…
Follow-up: What other technical communities get right that we do not Replied, post #119 · Lounge › Off topic · 3 Jun 2025 · 0 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #83 · Practice › Reconstitution · 2 Jun 2025 · 0 likes I think the 5 mg vial question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Anxiety in the first weeks: drug, situation, or both Replied, post #79 · Wellbeing › Mental health · 24 Apr 2025 · 17 likes Right — I had this wrong and I am glad to have read it before it mattered.
Reading order for a first week here, and what to skip until later Replied, post #50 · Start Here › Welcome · 24 Mar 2025 · 29 likes Offering a way to settle reading order rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #109 · Compounds › Semaglutide · 20 Mar 2025 · 0 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Payment mechanics and the recovery options that do not exist — what changed since Started this topic · Sourcing › Payments · 15 Mar 2025 · 0 likes On the subject in the title: Payment mechanics and the recovery options that do not exist — what changed since Working notes rather than a conclusion. A payments…
Reading a chromatogram someone posted without axes Replied, post #10 · Analytics › HPLC & UHPLC · 11 Mar 2025 · 26 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. System suitability testing: injections run before and during the…
Albumin binding and how it produces a long half-life Replied, post #13 · Pharmacology › Pharmacokinetics · 11 Mar 2025 · 6 likes Two things can be true about albumin binding at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #83 · Sourcing › Regulatory · 3 Mar 2025 · 8 likes Contradicting a claim in this subcategory is most useful when it comes with a link to the primary source and a date of access. That is the version I would defend. It is…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #68 · Sourcing › Regulatory · 2 Mar 2025 · 3 likes Taking post #67 at face value and following it one step further. A methods point on pharmaceutical compounding rules rather than a substantive one: if the comparison is…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #13 · Sourcing › Independent verification · 20 Feb 2025 · 2 likes Method has to travel with the number. A verification record without the method is not a record; it is a figure.
Assessing a warm arrival: the decision process Replied, post #4 · Sourcing › Logistics · 18 Feb 2025 · 2 likes Helpful, and easy to find again, which is half of what a good reply is.
Why mass spectrometry cannot tell you about an epimer Replied, post #52 · Analytics › Mass spectrometry · 9 Feb 2025 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
Review: a draft on reconstitution arithmetic, with objections Replied, post #7 · Documentation › Doc review · 31 Jan 2025 · 29 likes Answering the question post #6 raises rather than the one it answers. Review date disputes: if a maintained page's review date is approaching and it has not been…
Reading a supplementary appendix and finding the interesting part Replied, post #72 · Evidence › Trials · 20 Jan 2025 · 0 likes Post #69 describes the usual case. This is about the unusual one. Posting my reading a supplementary appendix numbers with the method attached so they can be discounted…
Recovery when intake is low: what to cut first Replied, post #91 · Nutrition & Training › Resistance training · 15 Jan 2025 · 0 likes Taking post #90 at face value and following it one step further. Where somebody is losing strength rapidly, the first questions are intake, sleep and total training…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #18 · Evidence › Meta-analyses · 13 Jan 2025 · 22 likes On post #16 — agreed on the reasoning, with one qualification. I would keep Reading a meta-analysis and the decision it usually gets used for separate in this thread.…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #112 · Analytics › Method validation · 6 Jan 2025 · 26 likes Adding the measurement that post #110 says would settle it. Offering a way to settle stability-indicating method rather than another opinion about it. Two measurements,…
What we do not know about retatrutide, listed explicitly Replied, post #44 · Compounds › Retatrutide · 5 Jan 2025 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #118 · Compounds › Oral incretins · 28 Dec 2024 · 3 likes On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same dose can have quite different plasma…
Injection-site reactions: describing them precisely enough to be useful Replied, post #78 · Practice › Side effects · 16 Dec 2024 · 4 likes I had written a reply contradicting post #74 and deleted it. Here is what survived. Effects that improve with time and effects that improve with dose reduction are…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #67 · Compounds › Tirzepatide · 3 Dec 2024 · 27 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
When "no data" is the complete and final answer Replied, post #30 · Compounds › Other compounds · 28 Nov 2024 · 18 likes Coming back to post #26, because the follow-up matters more than the original answer. Dose conversions between related compounds in this subcategory are made far too…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #35 · Compounds › Other compounds · 6 Oct 2024 · 6 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
Anxiety in the first weeks: drug, situation, or both Replied, post #2 · Wellbeing › Mental health · 17 Sep 2024 · 27 likes What I can speak to on anxiety is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Coming back to: Oxidation pathways for methionine and tryptophan Started this topic · Analytics › Impurities & related substances · 7 Aug 2024 · 0 likes Oxidation pathways for methionine and tryptophan Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #5 · Practice › Side effects · 26 Jul 2024 · 18 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
Where the four-week escalation interval comes from, and what it is not Replied, post #25 · Practice › Dosing & titration · 19 Jun 2024 · 6 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
Spreadsheets: an appreciation Replied, post #15 · Lounge › Off topic · 7 Jun 2024 · 22 likes I think the spreadsheets question is answerable and has not been answered, which is a more optimistic position than most of this thread.